Provided by Tiger Trade Technology Pte. Ltd.

Tyra Biosciences, Inc.

22.03
-1.5100-6.41%
Post-market: 22.170.1400+0.64%19:55 EDT
Volume:1.55M
Turnover:35.06M
Market Cap:1.31B
PE:-9.17
High:23.96
Open:23.63
Low:21.86
Close:23.54
52wk High:40.65
52wk Low:11.82
Shares:59.49M
Float Shares:35.21M
Volume Ratio:0.64
T/O Rate:4.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4031
EPS(LYR):-2.0125
ROE:-45.31%
ROA:-28.46%
PB:3.71
PE(LYR):-10.95

Loading ...

Enliven Therapeutics Q2 Net Loss Widens on Higher Expenses

Reuters
·
Aug 06

Tyra Biosciences price target lowered to $42 from $44 at Jefferies

TIPRANKS
·
Aug 06

Tyra Biosciences delayed cancer data by one month, says JonesResearch

TIPRANKS
·
Aug 06

Tyra Biosciences falls 20% after pushing data readout to September from August

TIPRANKS
·
Aug 06

Kymera Therapeutics Q2 Collaboration Revenue More than Doubles, Beats Estimates

Reuters
·
Aug 05

Analysts Are Bullish on Top Healthcare Stocks: Alphatec Holdings (ATEC), Tyra Bioscience (TYRA)

TIPRANKS
·
Aug 05

Tyra Biosciences Q2 EPS $(0.69) Misses $(0.65) Estimate

Benzinga Earnings
·
Aug 05

Tyra Biosciences - Amends Sales Agreement on Aug 4, 2026 to Increase Maximum Offering Price for Common Stock - SEC Filing

THOMSON REUTERS
·
Aug 05

Tyra Biosciences - May Offer and Sell up to $250 Mln of Common Stock Under Amended Sales Agreement - SEC Filing

THOMSON REUTERS
·
Aug 05

Tyra Biosciences Q2 FY26 Net Loss Widens to $45.56 Million; R&D Expenses Climb to $39.2 Million

Reuters
·
Aug 05

Tyra Biosciences Advances TYRA-200 Into First-in-Human FGFR2 Cancer Trial

TIPRANKS
·
Jul 30

Analyst Maintains Buy on Tyra Biosciences, Reiterates $50 Price Target on NMIBC Opportunity

TIPRANKS
·
Jul 22

Analysts Are Bullish on These Healthcare Stocks: Tyra Bioscience (TYRA), Eli Lilly & Co (LLY)

TIPRANKS
·
Jul 19

Tyra Biosciences: Buy Rating Reaffirmed, $50 Price Target Maintained on Strong Dabogratinib Potential

TIPRANKS
·
Jul 15

Tyra Biosciences Initiated at Buy by Jones Trading

Dow Jones
·
Jun 17

Tyra Biosciences initiated with a Buy at JonesResearch

TIPRANKS
·
Jun 17

Tyra Biosciences Inc : Jonestrading Initiates Coverage With Buy Rating; Target Price $56

THOMSON REUTERS
·
Jun 17

Analysts Offer Insights on Healthcare Companies: Spyre Therapeutics (SYRE) and Tyra Bioscience (TYRA)

TIPRANKS
·
Jun 16

Tyra Biosciences' Weak Investor Sentiment Reflects Macro Pressures, Renewed SURF-302 Concerns, BofA Says

MT Newswires Live
·
Jun 10

Tyra Biosciences Is Maintained at Buy by B of A Securities

Dow Jones
·
Jun 10